đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
Open-Label Extension and Safety Monitoring Study of Acoramidis (AG10) in Pa...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2021-10-27
Trial ID
NCT04988386
Treatments Being Tested
The study aims to evaluate the effect of acoramidis on cardiac functional a...
Status
Recruiting
Location
Washington University in St. Louis
Start Date
2026-07
Trial ID
NCT07695701
Treatments Being Tested
Transthyretin amyloidosis (ATTR) is a disease where the normally occurring ...
Status
Recruiting
Location
University of California, San Diego (UCSD) - Medical Center
Start Date
2025-05-12
Trial ID
NCT06563895
Treatments Being Tested
This is a single centre, open-label, 5-period study in healthy male and non...
Status
Completed
Location
Quotient Sciences
Start Date
2021-03-28
Trial ID
NCT04769479
Treatments Being Tested
This prospective study is designed to evaluate the efficacy, safety, and to...
Status
Completed
Location
Research Site
Start Date
2020-11-13
Trial ID
NCT04622046
Treatments Being Tested
Phase 3 efficacy and safety study to evaluate acoramidis (AG10) HCl 800 mg ...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2019-03-19
Trial ID
NCT03860935
Treatments Being Tested
The AG10-504 study is an open-label extension study of acoramidis in partic...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-11
Trial ID
NCT07116473
Treatments Being Tested
Phase 3 efficacy and safety of acoramidis in subjects with symptomatic Tran...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-09-08
Trial ID
NCT04882735
Treatments Being Tested
The purpose of this study is to determine the effect of a high-fat, high-ca...
Status
Completed
Location
Celerion
Start Date
2021-05-30
Trial ID
NCT04958135
Treatments Being Tested